Skip to main content
[Preprint]. 2024 Jun 6:rs.3.rs-4467983. [Version 1] doi: 10.21203/rs.3.rs-4467983/v1

Table 1:

Mean cytokine levels.

Control IFNγ ONX-0914 IFNγ+ONX-0914
BLC 866.50 1218.27 1508.71 1337.00
C5/C5a* 467.32 811.13 969.00 891.92
G-CSF* 151.79 465.61 534.88 411.57
GM-CSF Undetected 164.42 275.10 174.34
sICAM-1 14824.16 22037.30 21240.40 21870.84
IL-1ra* 3096.32 10518.27 4585.73 7466.45
IL-2 808.91 373.07 117.85 264.98
IL-3 792.38 1260.42 1407.41 1469.89
IL-4* 416.19 767.21 922.63 825.54
IL-5 84.65 380.33 393.02 290.82
IL-6 Undetected 168.73 209.51 60.62
IL-27* 51.76 387.53 189.89 255.20
IP-10** 1389.76 21515.35 1971.25 14879.69
I-TAC* 429.45 752.20 907.04 800.80
KC 93.74 379.99 384.28 208.07
M-CSF 9.02 401.14 453.96 74.95
MCP-1** 1029.59 2077.57 1458.85 885.17
MIG** Undetected 3707.30 35.24 1916.18
MIP-1alpha 7084.88 4003.13 9256.91 2516.37
RANTES** Undetected 932.45 47.91 270.62
SDF-1* 414.34 1229.00 1130.33 866.24
TARC 834.81 1133.93 1417.26 1343.51
TIMP-1 726.10 1129.15 1389.80 1177.04

BV-2 cells were treated for 24 hours then submitted to cytokine analysis. Values are mean pixel density of 4 independent experiments.

*

indicates a significant difference between control and IFNγ groups.

**

(p<0.05) indicates that ONX-0914 treatment reversed the IFNγ−dependent increase.